Loading company…
Atlanta-based cancer care platform for multidisciplinary case discussions, tumor conferences and clinical trial research.
Founded in 2015 and headquartered in Atlanta, US, OncoLens provides a multidisciplinary cancer care platform for integrated networks, community cancer centers and academic institutions. It supports tumor conference management and clinical trial participation for over 100 community cancer centers and oncology practices in the United States. Clients pay annual subscriptions. A Series B round on October 2, 2024, with investors including BIP Ventures and Cross-Border Impact Ventures, brought total funding to USD 12.865 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in